C12N 2760/16152
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2760/16152 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 75 US grants and 109 published applications in this corpus.
Search patents in C12N- Granted patents
- 75
- Published applications
- 109
- Assignees
- 64
- Inventors
- 196
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 1 | 1 |
| 2008 | 0 | 3 |
| 2009 | 1 | 3 |
| 2010 | 1 | 4 |
| 2011 | 0 | 7 |
| 2012 | 1 | 5 |
| 2013 | 4 | 8 |
| 2014 | 7 | 3 |
| 2015 | 7 | 7 |
| 2016 | 3 | 6 |
| 2017 | 6 | 6 |
| 2018 | 5 | 10 |
| 2019 | 4 | 3 |
| 2020 | 6 | 7 |
| 2021 | 3 | 7 |
| 2022 | 6 | 8 |
| 2023 | 4 | 7 |
| 2024 | 8 | 2 |
| 2025 | 2 | 6 |
| 2026 | 4 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Avian influenza vaccines and methods of making same28 Jul 2026US 12,691,170 B2The United States of America as represented by the Secretary of Agriculture
- Influenza virus backbone5 May 2026US 12,616,745 B2FluGen, Inc.
- Method for producing reassortant influenza viruses17 Mar 2026US 12,576,146 B2Seqirus UK Limited
- Hemagglutinin modifications for improved influenza vaccine production10 Mar 2026US 12,569,550 B2St. Jude Children?S Research Hospital
- Influenza virus hemagglutinin mutants30 Sep 2025US 12,428,661 B2Aramis Biotechnologies Inc.
- Influenza virus backbone9 Jul 2026US 2026/0191948 A1FluGen, Inc.
- Modified influenza viruses12 Mar 2026US 2026/0071191 A1Seqirus Inc.
- Duck-derived rna polymerase i promoter and recombinant vector carrying same16 Oct 2025US 2025/0320466 A1Republic of Korea (Animal and Plant Quarantine Agency)
- Influenza virus hemagglutinin mutants17 Apr 2025US 2025/0122549 A1Aramis Biotechnologies Inc.
- Modified vero cells and methods of using the same for virus production10 Apr 2025US 2025/0115881 A1Sanofi Pasteur Limited
Most cited
By later US patents
- Influenza virus replicated in mammalian cell culture and vaccine production54US 6,344,354 B12002
- Multi plasmid system for the production of influenza virus34US 8,093,033 B2MedImmune, LLC · 2012
- Method of purifying influenza virus and removing MDCK cell DNA contaminants32US 8,357,376 B2Memimmune, LLC · 2013
- Multi plasmids system for the production of influenza virus31US 8,409,843 B2MedImmune, LLC · 2013
- Production of vaccines30US 7,833,788 B2Crucell Holland B. V. · 2010